EODData

FRA, 3XV: XVIVO PERFUSION AB

19 Dec 2025
LAST:

16.80

CHANGE:
 0.17
OPEN:
16.80
HIGH:
16.80
ASK:
0.00
VOLUME:
30
CHG(%):
1.02
PREV:
16.63
LOW:
16.80
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
19 Dec 2516.8016.8016.8016.8030
18 Dec 2516.6316.6316.6316.6330
17 Dec 2516.4016.6016.4016.6030
16 Dec 2515.7515.7515.7515.75133
15 Dec 2516.2316.2316.2316.23133
12 Dec 2516.6616.6616.6616.66133
11 Dec 2516.0916.0916.0916.09133
10 Dec 2515.9815.9815.9815.98133
09 Dec 2516.6216.6216.6216.62133
08 Dec 2516.7016.7016.7016.70133

PROFILE

Name:XVIVO PERFUSION AB
About:Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally. The company was incorporated in 1998 and is headquartered in Mölndal, Sweden.
Sector:Healthcare
Address:Gemenskapens gata 9, Mölndal, Sweden, 431 53
Website:https://www.xvivogroup.com
ISIN:SE0004840718
LEI:549300G2464FYLS14B41

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:189.89 
Forward P/E:24.57 
PEG Ratio:-2.02 
Price to Sales:0.67 
Price to Book:0.26 
Profit Margin:0.04 
Operating Margin:0.09 
Return on Assets:0.02 
Return on Equity:0.01 
Revenue:73.92M 
EBITDA:6.32M 
Shares:31.5M 
Market Cap:529.19M 

TECHNICAL INDICATORS

MA5:16.402.4%
MA10:16.412.4%
MA20:16.253.4%
MA50:15.985.1%
MA100:15.995.1%
MA200:21.5328.2%
STO9:100.00 
STO14:100.00 
RSI14:50.62
MTM14:0.72
ROC14:0.04 
ATR:0.40 
Week High:16.800.0%
Week Low:15.756.7%
Month High:17.011.3%
Month Low:14.6028.2%
Year High:44.68166.0%
Year Low:14.4516.3%
Volatility:5.14